PlainRecalls
FDA Drug Moderate Class II Terminated

Amlodipine and Benazapril HCL Capsules, USP, 5 mg/40 mg, 100 count bottles, Mylan Pharmaceuticals, Inc., Morgantown, WV --- NDC 0378-6899-01

Reported: May 23, 2018 Initiated: April 24, 2018 #D-0820-2018

Product Description

Amlodipine and Benazapril HCL Capsules, USP, 5 mg/40 mg, 100 count bottles, Mylan Pharmaceuticals, Inc., Morgantown, WV --- NDC 0378-6899-01

Reason for Recall

cGMP Deviations; cleaning processes for equipment used to manufacture the specified batches was not followed according to procedure

Details

Units Affected
12,924 bottles
Distribution
Product was distributed throughout United States
Location
Morgantown, WV

Frequently Asked Questions

What product was recalled?
Amlodipine and Benazapril HCL Capsules, USP, 5 mg/40 mg, 100 count bottles, Mylan Pharmaceuticals, Inc., Morgantown, WV --- NDC 0378-6899-01. Recalled by Mylan Pharmaceuticals Inc.. Units affected: 12,924 bottles.
Why was this product recalled?
cGMP Deviations; cleaning processes for equipment used to manufacture the specified batches was not followed according to procedure
Which agency issued this recall?
This recall was issued by the FDA Drug on May 23, 2018. Severity: Moderate. Recall number: D-0820-2018.